Health insurers are passing on the high cost of some meds to patients, asking them to pay up to one-third the price of expensive drugs; the policies affect drugs for such serious illnesses as cancer, multiple sclerosis, and rheumatoid arthritis, and they apply even to meds without cheaper equivalents. Report